XPRO India Ltd Q1 FY26 Earnings Analysis
Published 14 Jun 2026 | Industrial Products | Market Cap: ₹2.5K Cr
Price
₹1,207
Market Cap
₹2.5K Cr
P/E Ratio
198.3
Earnings Summary
- Barjora line commercial production expected to start by September 2025, with near full capacity utilization anticipated next year. - The company is ramping up new production lines at Barjora (India) and Ras Al Khaimah (UAE), expected to boost future revenues significantly (INR150-200 crores per plant initially).
📊 Revenue & Sales Performance
- Barjora line commercial production expected to start by September 2025, with near full capacity utilization anticipated next year. - Revenue potential per new plant (Barjora and UAE) estimated in the range of INR150-200 crores initially, with growth expected as thinner films stabilize. - The Ras Al Khaimah (UAE) plant dry runs to begin in Q4 2025, targeting global markets, especially strategic exports to Europe and the USA. - Indian market demand is about 15,000 tons; Xpro currently meets ~30% of this, with a peer contributing similarly, together covering about 50%. - New capacities are aimed at replacing imports and capturing growing demand domestically and globally. - Capacitor manufacturers in India plan to expand capacity by about 50%, which will increase demand for Xpro's products. - Growth driven by demand for thinner, higher-value variants, and expansion in coextruded sheets and thermoform liners showing 25% production increase. - Overall, strong volume growth and revenue rise expected due to capacity ramp-up and market capture.
📈 Profitability & Margins
- The company is ramping up new production lines at Barjora (India) and Ras Al Khaimah (UAE), expected to boost future revenues significantly (INR150-200 crores per plant initially). - Growth driven by global demand for capacitor films and coextruded sheets, with the Indian dielectric film market having around 15,000 tons demand and the company holding ~33% market share. - Price adjustments have been made strategically to prepare for capacity additions rather than due to market compulsion, indicating a focus on long-term sustainable margins. - Expansion into Middle East is aimed at supplying global markets including the U.S., potentially reducing dependence on China and improving competitiveness. - EBITDA margins impacted recently due to Coex business growth (lower margin) and pricing strategy, but margins expected to improve when price corrections are implemented. - Company maintains near 100% utilization in dielectric film and expects steady improvement in profitability alongside capacity ramp-up.
🏗️ Capital Expenditure Plans
- Barjora plant (West Bengal) has started dry runs; commercial production expected around September 2025. - Ras Al Khaimah (RAK), UAE project under construction; dry runs expected in the last quarter of 2025. - Barjora line has a revenue potential of INR150-200 crores per annum at start; UAE plant similar. - Capital funding for Barjora and UAE plants is tied up; pending replacement of some damaged components by mid-June 2025. - Total capital raised through warrants and QIP being utilized as planned; promoter group invested with lock-in. - Both projects faced supply/logistical delays due to customized machinery and transit damages but are now on track. - The company holds fixed deposits as balance capex funds for plant setup. - Barjora capacity ramp-up to full utilization expected next year. - Strategy focuses on reducing imports and capturing domestic and export markets with new capacities.
💰 Fundraising & Capital Structure
- No new fundraising through debt or equity is currently planned. - The funding for the Barjora and UAE plant projects is broadly complete, with all arrangements tied up. - Balance requirements for plant construction are held in fixed deposits. - Capital raised through previous preferential issues and QIP is being utilized as intended. - Promoter group has invested in preferential offers and converted warrants early, subject to longer lock-in periods. - Equity capital is expected to rise upon full conversion of outstanding warrants by July 2025. - No outstanding long-term borrowings for existing operations. - The company opted for supplier credit (ECB) for the Barjora line setup, increasing long-term debt by INR110 crores.
📋 Order Book & Pipeline
- The transcript does not explicitly mention specific details about the current or expected order book or pending orders for Xpro India Limited. - However, it is indicated that the company has strong customer tie-ups for the Barjora line, with many customers eagerly waiting and ready for formal deliveries. - The company expects to ramp up capacity utilization close to full capacity next year for the new Barjora line. - Expansion projects like the Ras Al Khaimah plant are progressing steadily, with dry runs expected in the last quarter of the calendar year, indicating future order fulfillment capabilities. - The company focuses on capitalizing on domestic demand and importing replacement, implying an active pipeline of business. - Customers, including big capacitor manufacturers, are expanding capacity, indicating expected steady or growing orders from existing clients. - Overall, demand appears strong with ready markets and strategies in place to quickly load new capacities.
Key Metrics
Frequently Asked Questions
What were XPRO India Ltd Q1 FY26 results?
- Barjora line commercial production expected to start by September 2025, with near full capacity utilization anticipated next year. - The company is ramping up new production lines at Barjora (India) and Ras Al Khaimah (UAE), expected to boost future revenues significantly (INR150-200 crores per plant initially).
What is XPRO India Ltd share price analysis?
XPRO India Ltd currently shows a neutral. The stock trades at a P/E of 198.3 with a market cap of ₹2,546. Investors should review the full earnings analysis for detailed insights.
Is XPRO India Ltd planning capital expenditure?
- Barjora plant (West Bengal) has started dry runs; commercial production expected around September 2025.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
